Patient in Focus (www.patientinfocus.org) is part of a multi-stakeholder initiative on cross-border access to clinical trials (EU-X-CT). The project aims to analyse the current situation of cross-border access to clinical trials in the EU with an overview of stakeholders’ real-life experiences and to identify needs, challenges and potential to facilitate cross-border access. Today there is over 50 organizations from industry, academia, and patient organizations, all of which have agreed to participate in this project.
To support patient communities, investigators, and trial sponsors in enabling cross-border access to clinical trials when appropriate, EFGCP and EFPIA have set up a multi-stakeholder consortium of patient organisations, academia, research networks and industry with the aim to develop recommendations to enable cross-border access to clinical trials for patients across the EU.
With no current European Framework to define the conditions for cross border clinical trials, the project will map out the current state of each Member State, detailing the logistical and financial support required as well as issues like accessing ongoing treatment for those patients involved. The project will be vital in bringing groundbreaking trials to patients in countries who previously had no access and could revolutionise treatment options for those with rare diseases.
Read the full press release here
Patient in Focus (www.patientinfocus.org) is an international, disease neutral, nonprofit patient organization based in Europe. Built by patients for patients. Patient in Focus provides the opportunity to make a difference for yourself and others by being a voice with healthcare professionals, researchers, industry, academics etc. We do this through patient engagement, counseling, and a strong patient community, where we can create life-changing purpose and quality of life despite chronic illness, pain, and disabled.